Publications by authors named "Simone Pinna"

Claim this Profile
M
Medical source control with oritavancin in complicated gram-positive bacterial infections: A case series.
Francesco Giuseppe De Rosa, Tommaso Lupia, Valentina Fornari, Rita Viglianti, Saverio Marena, Simone Mornese Pinna

Int J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections.
Nicholas Geremia, Federico Giovagnorio, Antonio Vena, Silvia Corcione, Maddalena Giannella, Simone Mornese Pinna

Infection· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience.
Francesca Serapide, Riccardo Serraino, Luigi Spadafora, Marco Bernardi, Giorgia Brucci, Simone Mornese Pinna

J Antimicrob Chemother· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefiderocol for the Treatment of Nosocomial Bloodstream Infections Caused by Stenotrophomonas maltophilia: A Case Series and Literature Review.
Antonio Vena, Laura Mezzogori, Nadia Castaldo, Silvia Corcione, Renato Pascale, Simone Mornese Pinna

Infect Dis Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ChatGPT as a prospective undergraduate and medical school student.
Marco Giunti, Fabrizia Giulia Garavaglia, Roberto Giuntini, Giuseppe Sergioli, Simone Pinna

PLoS One· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study.
Marianna Meschiari, Alessandro Cozzi-Lepri, Adriana Cervo, Guido Granata, Carlotta Rogati, Simone Mornese Pinna

Int J Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.
Theodossis Papavramidis, Ivan Gentile, Anna Maria Cattelan, Laura Magnasco, Pierluigi Viale, Simone Mornese Pinna

Int J Antimicrob Agents· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nodular Cutaneous Lesions in Immune-Compromised Hosts as a Clue for the Diagnosis of Disseminated Nocardiosis: From Bedside to Microbiological Identification.
Ilaria De Benedetto, Antonio Curtoni, Tommaso Lupia, Simone Mornese Pinna, Silvia Scabini

Pathogens· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Experience of Molnupiravir in Hospitalized Patients Who Developed SARS-CoV2-Infection: Preliminary Results from CORACLE Registry.
Tommaso Lupia, Silvia Corcione, Nour Shbaklo, Lucio Boglione, Stefano Torresan, Simone Mornese Pinna

Antibiotics (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key?
Silvia Corcione, Ilaria De Benedetto, Simone Mornese Pinna, Davide Vita, Tommaso Lupia

J Infect Public Health· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an empiric antimicrobial therapy manual on antimicrobial usage and multidrug resistant organism trends in a large Italian teaching hospital.
Silvia Corcione, Nour Shbaklo, Costanza Vicentini, Alessio Corradi, Silvia Scabini, Simone Mornese Pinna

Infect Prev Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver involvement and mortality in COVID-19: A retrospective analysis from the CORACLE study group.
Lucio Boglione, Silvia Corcione, Nour Shbaklo, Tiziana Rosso, Tommaso Lupia, Simone Mornese Pinna

Infez Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dispersion of Few-Layer Black Phosphorus in Binary Polymer Blend and Block Copolymer Matrices.
Serena Coiai, Elisa Passaglia, Simone Pinna, Stefano Legnaioli, Silvia Borsacchi

Nanomaterials (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review.
Tommaso Lupia, Silvia Corcione, Francesco Guerrera, Lorena Costardi, Enrico Ruffini, Simone Mornese Pinna

Surg Infect (Larchmt)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 pneumonia: do not leave the corticosteroids behind!
Simone Mornese Pinna, Silvia Scabini, Silvia Corcione, Tommaso Lupia, Francesco G De Rosa

Future Microbiol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with sofosbuvir/velpatasvir in cirrhotic patients with genotype-4 who failed a previous interferon-free regimen: a case series.
Lucio Boglione, Simone Mornese Pinna, Tommaso Lupia, Giuseppe Cariti, Giovanni Di Perri

Antivir Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy.
Jessica Cusato, Amedeo De Nicolò, Lucio Boglione, Fabio Favata, Alessandra Ariaudo, Simone Mornese Pinna

Pharmacogenomics· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
Lucio Boglione, Jessica Cusato, Simone Mornese Pinna, Amedeo De Nicolò, Giuseppe Cariti

Arch Virol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors.
Lucio Boglione, Simone Mornese Pinna, Chiara Simona Cardellino, Amedeo De Nicolò, Jessica Cusato

Infection· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis